Tumors News, Articles | Today's Clinical Lab

Illustration of a magnifying glass with the word “cancer” in the middle against a gold background.

First Patient Dosed in Phase 1 Trial of OKN4395, a First-in-Class EP2/EP4/DP1 Triple Inhibitor for Patients with Solid Tumors

Owkin

OKN4395 is the first compound to be developed using K1.0, Owkin’s AI-powered operating system

Photo of Kirk Staschke and Noah Sommers, a PhD student at the IU School of Medicine, at the microscope.

Researchers Find New Way to ‘Starve’ Prostate Cancer Tumors at the Cellular Level

Indiana University

Prostate cancer is a leading cause of cancer deaths in American men

Photo of a micrograph of endometriosis stained tissue section in a patient with BRCA1 mutation.

Study Finds Novel Role of BRCA1 in Tumor Suppression

University of Texas Health Science Center at San Antonio

The study helps explain why BRCA1 is such an important tumor suppressor in breast and ovarian cancers

Diagram of the new automated workflow of the BOND RX Fully Automated Research Stainer.

New Fully Automated Proximity Ligation Assays Aim to Simplify, Standardize Workflows

Leica Biosystems

The new platform will help researchers better understand cell-to-cell interactions in tumor microenvironments, benefitting future development of targeted cancer therapies

A microscopic image of a lung cancer tissue biopsy showing stained tumor cells.

Novel Nanopipette Could Advance Single-Cell Analysis

University of Leeds

Learning how tumor cells adapt to treatment through nanobiopsy could aid in preventing cancer recurrence

A graphical visualization of DNA bands and sequencing data arranged in concentric circles that form a network at the center.

Advances in Genomic Lab Services Drive Patient-Centered Clinical Trials

David Latto, PhD

How can clinical trial sponsors employ genomic data insights to propel patient-centered drug discovery and development?

3D illustration of monoclonal antibodies attacking tumor cells with high vascularization.

mAb Combo Therapy Safe to Treat Advanced Cancers

Wiley

CS1002 plus CS1003 showed promising antitumor activity and had a manageable safety profile across a broad dosing range in trials

A cheerful senior African American woman, wearing a pink ribbon on the left side of her chest, smiles as she attends an outdoor breast cancer awareness event.

Androgen Receptor Modulator Drug Could Improve Breast Cancer

University of Liverpool

Phase 2 trial results indicate benefits of the new way of treating advanced ER+ breast cancer

Epigenetic therapies are a new class of drugs that focus on modifying the activity of genes without changing the underlying DNA sequence.

Epigenetic Combo Therapy Shows Promise Against Rare Sarcomas

Memorial Sloan Kettering Cancer Center

The team’s next step is to introduce immunotherapy to treat soft tissue sarcomas

A vector illustration of storing umbilical cord blood cells.

Cord Blood-Derived CAR NK-Cell Therapy Safe for B-Cell Malignancies

University of Texas MD Anderson Cancer Center

Researchers identified characteristics of donated cord blood units associated with strong clinical responses in the Phase 1/2 trial

Tumors